Dispensed, Healthcare, pharma, Biotech, m&a, Deals, Acquisition,

2 crucial voices that could decide the fate of the $74 billion BMS-Celgene deal just came out in favor of the record-breaking takeover

By

Brendan McDermid/ Reuters Institutional Shareholder Services and Glass Lewis, two influential voices in corporate brawls, have come out in favor of Bristol-Myers Squibb’s $74 billion takeover of the biotech Celgene. The deal has faced growing unhappiness from shareholders, especially the vocal activist Starboard. Investors are set to vote on the deal at an April 12 […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.